Population Pharmacokinetic of Tacrolimus in Tunisian Renal Transplant Patients: Influence of CYP34A and CYP3A5 Polymorphisms

被引:0
|
作者
Ben-Fredj, N. [1 ]
Hannachi, I. [1 ,2 ]
Chadli, Z. [1 ]
Kerkeni, E. [1 ]
Ben-Romadhane, H. [1 ]
Ben-Fadhel, N. [1 ]
Hammouda, M. [3 ]
Boughattas, N. A. [1 ]
Chaabane, A. [1 ]
Aouam, K. [1 ]
机构
[1] Univ Monastir, Fac Med, Pharmacol Lab, Monastir, Tunisia
[2] Carthage Univ, Fac Sci Bizerte, Monastir, Tunisia
[3] Univ Hosp Monastir, Dept Nephrol, Monastir, Tunisia
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS2-024
引用
收藏
页码:74 / 74
页数:1
相关论文
共 50 条
  • [41] THE EFFECT OF CYP3A5 POLYMORPHISMS ON LONG TERM TACROLIMUS DISPOSITION IN RENAL RECIPIENTS
    Imperiali, Nora C.
    Larriba, Julian M.
    Groppa, Silvia R.
    Giordani, Maria C.
    Maule, Gabriel B.
    Mombelli, Cesar A.
    Bratti, Griselda I.
    Argibay, Pablo F.
    Algranati, Salomon L.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 81
  • [42] Association Between CYP3A5☆1 and CYP3A5☆3 Polymorphisms, With the Formation of ADES and the Presence of Rejection in Renal Transplant Recipients
    Garcia, Luis
    Quintanilla, Alan
    Hinojosa, Hector
    Vargas, Lionel
    Fernandez, Diana
    Garcia, Aldo
    TRANSPLANTATION, 2022, 106 (09) : S275 - S275
  • [43] The population pharmacokinetics of sirolimus and CYP3A5*3 polymorphism in Chinese renal transplant patients
    Shi, Hao-Qiang
    Yang, Jun
    Zhang, Li-Qun
    Xu, Bei-Ming
    Lu, Hui-Lan
    Chen, Er-Zhen
    Chen, Bing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 5854 - 5866
  • [44] Influence of CYP3A5, IL-10 polymorphisms and metabolism rate on tacrolimus exposure in renal post-transplant recipients
    Cheng, Xi
    Chen, Yuhao
    Zhang, Lei
    Chen, Biwen
    Yang, Dake
    Chen, Weihuang
    Zhu, Pengli
    Fang, Zhuo
    Chen, Zhaolin
    PHARMACOGENOMICS, 2022, 23 (18) : 961 - 972
  • [45] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [46] Effect of CYP 3A4*1B and CYP3A5*3 Gene Polymorphisms in Antirejection of Tacrolimus in Liver Transplant Patients
    Zhou, Xia
    Tang, Rujia
    Zhang, Dali
    He, Xi
    Liu, Zhenwen
    Gao, Yinjie
    Liu, Hongling
    TRANSPLANTATION PROCEEDINGS, 2025, 57 (02) : 298 - 304
  • [47] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [48] The impact of CYP3A5*3 and CYP3A4*22 polymorphisms on Tacrolimus pharmacokinetics in a caucasian kidney transplant cohort
    Abdel-Kahaar, E.
    Winter, S.
    Schaeffeler, E.
    Olbricht, C.
    Shipkova, M.
    Schwab, M.
    Wieland, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S74 - S74
  • [49] Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population
    Madadov, Islam
    Baimakhanov, Bolatbek
    Yernur, Belgibayev
    Nabiyev, Elshad
    Saduakas, Nursultan
    Rgebayev, Berik
    Bolysbayeva, Farida
    Bayzhan, Aruzhan
    Kali, Altynai
    TRANSPLANTATION, 2024, 108 (09) : 370 - 370
  • [50] Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population
    Madadov, Islam
    Baimakhanov, Bolatbek
    Yernur, Belgibayev
    Nabiyev, Elshad
    Saduakas, Nursultan
    Rgebayev, Berik
    Bolysbayeva, Farida
    Bayzhan, Aruzhan
    Kali, Altynai
    TRANSPLANTATION, 2024, 108 (9S)